Variant NM_000492.4:c.743+40A>G
Name | NM_000492.4:c.743+40A>G |
Protein name | NP_000483.3:p.(=) |
Genomic name (hg19) | chr7:g.117175505A>G UCSC |
#Exon/intron | intron 6 |
Legacy Name | 875+40A/G |
Class | non disease-causing |
WT sequence | TCATAACTTGAAAGTTTTAAAAATT A TGTTTTCAAAAAGCCCACTTTAGTA |
Mutant sequence | TCATAACTTGAAAGTTTTAAAAATT G TGTTTTCAAAAAGCCCACTTTAGTA |
Not found | dbSNP rs1800502 |
Not found |
23 individuals carrying this variant are reported in CFTR-NGS catalogue |
TOTAL NUMBER OF PATIENTS | 96 |
---|---|
Asymptomatic compound heterozygote | 7 |
CF | 35 |
CFTR-RD | 52
|
Pending (NBS) | 2 |
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
Phenotype | Patient ID | Variant status | Additional variants |
---|---|---|---|
CF | 5215 | heterozygote | VUS3- Undef CFTR-RD-causing- Undef CFTR-RD-causing- Undef |
CF | 5069 | heterozygote | CF-causing- Undef VUS3- Undef varying clinical consequence- Undef |
CF | 1584 | heterozygote | CF-causing- Undef CF-causing- Undef |
CF | 1535 | heterozygote | CF-causing - Cis CFTR-RD-causing - Cis CF-causing - Trans |
CF | 5807 | heterozygote | CF-causing- Undef VUS3- Undef |
CF | 1289 | heterozygote | CF-causing- Undef CF-causing- Undef |
CF | 1293 | heterozygote | varying clinical consequence- Undef CF-causing- Undef |
CF | 1517 | heterozygote | VUS3- Undef CF-causing- Undef CF-causing- Undef |
CF | 1528 | heterozygote | |
CF | 4538 | heterozygote | VUS3- Undef CF-causing- Undef CF-causing- Undef |
CF | 4553 | heterozygote | CF-causing- Undef CF-causing- Undef |
CF | 5341 | heterozygote | VUS3- Undef CF-causing- Undef |
CF | 5777 | heterozygote | VUS3- Undef CF-causing- Undef VUS3- Undef |
CF | 3476 | heterozygote | CF-causing- Undef CF-causing- Undef |
CF | 3575 | heterozygote | CF-causing - Cis CF-causing - Trans |
CF | 4043 | heterozygote | CF-causing- Undef CF-causing- Undef |
CF | 270 | heterozygote | CF-causing- Undef CF-causing- Undef |
CF | 379 | heterozygote | CF-causing- Undef CF-causing- Undef |
CF | 247 | heterozygote | VUS3- Undef CF-causing- Undef |
CF | 232 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CF | 204 | heterozygote | VUS3- Undef CF-causing- Undef CF-causing- Undef |
CF | 111 | heterozygote | varying clinical consequence- Undef CF-causing- Undef |
CF | 138 | heterozygote | CF-causing - Cis CF-causing - Trans |
CF | 143 | heterozygote | CF-causing- Undef CF-causing- Undef |
CF | 145 | heterozygote | CF-causing - Cis CF-causing - Trans |
CF | 169 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CF | 882 | heterozygote | VUS3- Undef CF-causing- Undef |
CF | 985 | heterozygote | CF-causing - Cis CF-causing - Trans |
CF | 1005 | heterozygote | CF-causing - Cis CF-causing - Trans |
CF | 1006 | heterozygote | CF-causing - Cis CF-causing - Trans |
CF | 26 | homozygote | c.3846G>A - p.(Trp1282*) - Trans |
CF | 28 | homozygote | c.3846G>A - p.(Trp1282*) - Trans |
CF | 129 | homozygote | c.3883_3886del - p.(Ile1295Phefs*32) - Trans |
CF | 136 | homozygote | c.3846G>A - p.(Trp1282*) - Trans |
CF | 112 | homozygote | c.3883_3886del - p.(Ile1295Phefs*32) - Trans |
Other | 4627 | heterozygote | CFTR-RD-causing- Undef CFTR-RD-causing- Undef |
Other | 5575 | heterozygote | VUS3- Undef CF-causing- Undef |
Other | 5224 | heterozygote | VUS3- Undef VUS3- Undef |
Other | 1089 | heterozygote | varying clinical consequence - Trans |
Other | 4315 | heterozygote | varying clinical consequence- Undef |
Other | 4520 | heterozygote | CFTR-RD-causing- Undef CF-causing- Undef |
Other | 4826 | heterozygote | VUS3- Undef CFTR-RD-causing- Undef |
Other | 4686 | heterozygote | VUS3- Undef CF-causing- Undef |
Other | 5082 | heterozygote | CF-causing- Undef VUS3- Undef |
Other | 935 | heterozygote | CFTR-RD-causing- Undef |
Pending (NBS) | 4694 | heterozygote | CF-causing- Undef CFTR-RD-causing- Undef |
Pending (NBS) | 803 | heterozygote | VUS2- Undef CF-causing- Undef |
Pancreatitis | 4619 | heterozygote | VUS3- Undef VUS3- Undef |
Pancreatitis | 4849 | heterozygote | CF-causing - Cis CF-causing - Trans |
Pancreatitis | 4250 | heterozygote | VUS3- Undef |
Pancreatitis | 5155 | heterozygote | CFTR-RD-causing- Undef VUS3- Undef VUS3- Undef |
Pancreatitis | 4581 | heterozygote | VUS3- Undef CF-causing- Undef |
Pancreatitis | 4708 | heterozygote | VUS3- Undef VUS3- Undef |
Bronchiectasis | 5972 | heterozygote | VUS3- Undef varying clinical consequence- Undef |
Bronchiectasis | 4550 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
Bronchiectasis | 4242 | heterozygote | CF-causing- Undef |
Bronchiectasis | 5624 | heterozygote | VUS3- Undef CF-causing- Undef |
Bronchiectasis | 5076 | heterozygote | VUS3- Undef |
Bronchiectasis | 4870 | homozygote | c.1054C>T - p.(Arg352Trp) - Trans c.1210-34_1210-6TG[11]T[5] - Trans c.1210-34_1210-6TG[12]T[5] - Trans |
CBAVD | 5022 | heterozygote | VUS3- Undef CFTR-RD-causing- Undef VUS3- Undef varying clinical consequence- Undef |
CBAVD | 3388 | heterozygote | VUS3- Undef CF-causing- Undef |
CBAVD | 1276 | heterozygote | VUS3- Undef CFTR-RD-causing- Undef |
CBAVD | 5330 | heterozygote | CF-causing- Undef CFTR-RD-causing- Undef |
CBAVD | 4524 | heterozygote | CF-causing- Undef likely CFTR-RD- Undef |
CBAVD | 4271 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CBAVD | 5768 | heterozygote | CF-causing- Undef VUS3- Undef |
CBAVD | 396 | heterozygote | |
CBAVD | 416 | heterozygote | varying clinical consequence- Undef CF-causing- Undef |
CBAVD | 436 | heterozygote | CF-causing- Undef CFTR-RD-causing- Undef |
CBAVD | 445 | heterozygote | CFTR-RD-causing- Undef CF-causing- Undef |
CBAVD | 443 | heterozygote | |
CBAVD | 453 | heterozygote | CF-causing- Undef CFTR-RD-causing- Undef |
CBAVD | 455 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 881 | heterozygote | VUS3- Undef varying clinical consequence- Undef |
CBAVD | 887 | heterozygote | CFTR-RD-causing- Undef CF-causing- Undef |
CBAVD | 919 | heterozygote | VUS3- Undef non-CF- Undef CF-causing- Undef |
CBAVD | 949 | heterozygote | VUS3- Undef CF-causing- Undef |
CBAVD | 812 | heterozygote | CFTR-RD-causing- Undef CF-causing- Undef |
CBAVD | 781 | heterozygote | VUS3- Undef |
CBAVD | 529 | heterozygote | VUS3- Undef CF-causing- Undef VUS3- Undef |
CBAVD | 484 | heterozygote | CF-causing- Undef CFTR-RD-causing- Undef |
CBAVD | 676 | heterozygote | VUS3- Undef |
CBAVD | 710 | heterozygote | CF-causing- Undef CFTR-RD-causing- Undef |
CBAVD | 725 | heterozygote | VUS3- Undef non-CF- Undef CF-causing- Undef |
CBAVD | 462 | heterozygote | CF-causing- Undef CFTR-RD-causing- Undef CFTR-RD-causing- Undef |
CBAVD | 503 | heterozygote | CFTR-RD-causing- Undef CFTR-RD-causing- Undef CFTR-RD-causing- Undef CFTR-RD-causing- Undef |
CBAVD | 440 | homozygote | c.1210-34_1210-6TG[11]T[5] - Trans |
Asymptomatic compound heterozygote | 3235 | heterozygote | VUS3 - Cis CFTR-RD-causing - Trans |
Asymptomatic compound heterozygote | 4628 | heterozygote | VUS3- Undef CFTR-RD-causing- Undef |
Asymptomatic compound heterozygote | 4763 | heterozygote | CF-causing- Undef CFTR-RD-causing- Undef |
Asymptomatic compound heterozygote | 4741 | heterozygote | CFTR-RD-causing- Undef CFTR-RD-causing- Undef |
Asymptomatic compound heterozygote | 4375 | heterozygote | CF-causing- Undef VUS2- Undef |
Asymptomatic compound heterozygote | 4523 | heterozygote | CFTR-RD-causing- Undef varying clinical consequence- Undef |
Asymptomatic compound heterozygote | 5362 | heterozygote | VUS3- Undef VUS3- Undef |
Aquagenic palmoplantar keratoderma | 5149 | heterozygote | VUS3- Undef CF-causing- Undef |
CRS-NP | 4276 | heterozygote | VUS3- Undef |
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
CFTR variants are clustered into five groups: |
|